Atrium Innovations. (ATB.TO) Buy, Sell or Hold

Atrium Innovations. (ATB.TO)

0.00

-0.00 (0.00%)

10 watching

BUY

Leading manufacturer/distributor of high quality vitamins/supplements, mostly sold through practitioners in US and Europe. Recently acquired a Canadian company. Growing business and now in health food stores in North America. One question is in their European operations with their product Robenzein (?), which is being transitioned from a drug to a food product where sales are off a bit but should start ramping up again.

PAST TOP PICK

(Top Pick Feb 27/09, Up 17%) Largest producer of high quality supplements. Best balance sheet in the business. They are an industry consolidator.

BUY

Food supplements, health care supplements. Has grown quite a bit, through acquisition. Be careful that the rules don’t change on supplements.

TOP PICK

Growth stock with lots of potential and not much downside. Largest North American company that produces and sells high quality nutritional supplements to practitioners. Major player in Europe with a major product that is the #3 painkiller that has been declassified as a food for wider distribution. Good cash position and lots of borrowing capacity to make acquisitions.

BUY

It is the leading company in Europe and N.A. in high quality vitamin and supplement business. It is the consolidator, slowly buying up companies, supplying practitioners. Well run company, earnings outlook is good. As population ages, more people are going to naturopaths. Doesn’t expect a dividend for a long time. It’s keeping cash for acquisitions. Their history is excellent for acquisitions.

TOP PICK

(A Top Pick Nov 11/08. Up 21.4%.) Canadian healthcare supplements with most operations in the US and Europe. Acquiring and growing organically and margins are increasing. Sells at a lower multiple than its comparables in the US.

TOP PICK

Health supplements. Has been growing through both organic and acquisitions. Has about 13% US market share and are quite strong in Europe. Their intention is to grow to about 20% market share. Attractively priced at about 8X forward earnings.

HOLD

Health foods. Still above his Stop but is very close. Chart shows it heading down when all other stocks are heading up. Thinks there will be support around $11.50. There have been no big fundamental changes on the company.

TOP PICK

Health supplements and sells through healthcare practitioners. Fairly good market share in North America. Currently at its support level. Has the potential to grow steadily. Stoploss would be $11.50.

BUY

High-end vitamins. Earnings are expected to grow by 9% this year and 11% next year against a 7 PE. Seems to be recession resistance.

TOP PICK

Biggest part of their business is food supplements (alternative medicine). Expecting more growth through acquisitions. Earnings per share are expected to be around $1.50 this year. 9X earnings. Most of the earnings is free cash flow.

BUY

Sales in health food stores are increasing. Recently acquired another company. Earnings are good. Earnings growth has been good. 33% expected. He is considering buying it.

BUY

(Market Call Minute.) Likes this one. Trades at about 10 or 11 times earnings. Good cash flow.

TOP PICK

Largest high-quality vitamin and supplement producer in North America and one of the largest nutrition supplement producers in Europe. More than half its earnings come from Europe now. Has used its balance sheet to make great acquisitions. Earnings are growing.

PAST TOP PICK

(A Top Pick Nov 19/07. Down 47%.) Food supplements but will people spend money on this in a recession? Last quarter was good indicating they have not got hit yet. Generates a lot of free cash flow. Most of their sales are in Europe and US so they benefit from the lower Cdn$. Stock is cheap.

Showing 16 to 30 of 58 entries

Most Recent Experts

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Joe Terranova

Virtus Investment Partners

Paul Harris, CFA

Harris Douglas Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Atrium Innovations. (ATB.TO)